OUR CAPABILITIES

  • 2015 Analytical/ Formulation/ Bio Process Development/ Synthesis Lab Q4 2015   
  • 2016 Microbial Pilot Plant ,5L~300L   
     Aseptic Injectables Pilot Plant , 4000 Vials/ Batch   
  • 2017 Aseptic Injectables Plant , 40,000 Vials/ Batch   
     Dedicated Oncology API & Lyophilization Vial Plant , 40,000 Vials/ Batch   
     Peptide Pilot Plant   
  • 2018 Cartridge Pen Injector Line,2,000 Pen/Hour
      Pre-Filled Syringe Line ,>10,000 PFS/Hour
  • 2019 Microbial Commercial Plant, 3,000LX2 ,under construction   
     Animal Cell Production Pilot Plant   
     Animal Cell Production Commercial Plant (Monoclonal Antibody Drugs)   
Genovior is in progress of building world class facilities that fully comply with the regulations of FDA, EMA and other agencies. The factories are equipped with state-of-art equipment which can furnish a total solutions for any of your projects: from process development of synthesis, microbial fermentation, purification, lyophilization and slow-release formulation, from piloting production to commercial contract manufacturing of either API or aseptic injectables.
 
     * Dedicated facility

Our facilities are located in Northern and Southern of Taiwan, details could be found from below